Delayed antivenom for life-threatening tiger snake bite: Lessons learnt

Area of Science:

• Toxicology
• Pharmacokinetics
• Clinical Medicine

Background:

• Snakebite envenomation presents significant clinical challenges.
• Tiger snake (Notechis spp.) venom can cause severe systemic effects, including respiratory failure, rhabdomyolysis, and consumption coagulopathy.
• The optimal timing and dosage of antivenom for tiger snake envenomation remain areas for further investigation.

Purpose of the Study:

• To report a case of severe tiger snake envenomation treated successfully with delayed antivenom administration.
• To emphasize the importance of recognizing and managing severe envenomation promptly.
• To highlight the need for pharmacokinetic studies on venom-antivenom interactions.

Main Methods:

• A case study of an adolescent with a tiger snakebite.
• Clinical monitoring of envenomation effects.
• Measurement of tiger snake venom antigen and antivenom levels in blood.
• Administration of tiger snake antivenom 48 hours post-bite.

Main Results:

• The patient experienced respiratory failure, rhabdomyolysis, and consumption coagulopathy.
• Tiger snake venom antigen was detectable before antivenom administration but not afterward.
• Antivenom was measurable in the patient's blood for nine days post-administration.
• The patient recovered following delayed antivenom therapy.

Conclusions:

• Delayed antivenom administration can facilitate recovery from severe tiger snake envenomation.
• This case underscores the necessity for further research into the pharmacokinetics of venom-antivenom interactions.
• Accurate dosing and timing of antivenom are critical for optimizing treatment outcomes in snakebite victims.